Bolt Biotherapeutics, Inc. (BOLT)
NASDAQ: BOLT · IEX Real-Time Price · USD
1.160
+0.010 (0.87%)
At close: Apr 26, 2024, 10:22 AM
1.110
-0.050 (-4.31%)
After-hours: Apr 26, 2024, 4:00 PM EDT
Bolt Biotherapeutics Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for BOLT stock have an average target of 6.00, with a low estimate of 4.00 and a high estimate of 8.00. The average target predicts an increase of 417.24% from the current stock price of 1.16.
Analyst Consensus: Strong Buy
* Price targets were last updated on Mar 22, 2024.
Analyst Ratings
The average analyst rating for BOLT stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 1 | 1 | 1 | 1 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $8 | Strong Buy | Maintains | $8 | +589.66% | Mar 22, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $8 | Strong Buy | Reiterates | $8 | +589.66% | Aug 8, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $8 | Strong Buy | Reiterates | $8 | +589.66% | Aug 3, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $8 | Strong Buy | Reiterates | $8 | +589.66% | Jun 5, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $8 | Strong Buy | Reiterates | $8 | +589.66% | May 26, 2023 |
Financial Forecast
Revenue This Year
9.13M
from 7.88M
Increased by 15.93%
Revenue Next Year
5.82M
from 9.13M
Decreased by -36.28%
EPS This Year
-1.79
from -1.83
EPS Next Year
-1.18
from -1.79
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 13.2M | 11.7M | 157.5M | 21.0M | 99.7M |
| Avg | 9.1M | 5.8M | 55.0M | 11.6M | 54.9M |
| Low | 5.9M | n/a | n/a | 2.6M | 12.4M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 67.0% | 27.8% | 2,607.1% | -61.8% | 761.5% |
| Avg | 15.9% | -36.3% | 844.8% | -78.9% | 374.4% |
| Low | -25.3% | - | - | -95.2% | 7.5% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -1.48 | -0.26 | 0.16 | -1.99 | -1.19 |
| Avg | -1.79 | -1.18 | -0.86 | -1.94 | -1.15 |
| Low | -1.92 | -1.69 | -1.49 | -1.86 | -1.11 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | - |
| Avg | - | - | - | - | - |
| Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.